This startup may have cured the incurable

The company behind this cannabis cure is still private Please do not reply to this message, as replies are routed to an unmonitored mailbox. You are receiving this email as a part of your subscription to Daily Trade Alliance. Your ability to alter your subscription information can be found at the bottom of this email. [Trading and Investing Pros] Dear Reader, A tiny startup just released a stunning video... [This video]( shows what appears to be a cure for an "incurable" disease. The most amazing part? This potential cure is based on a molecule in the cannabis plant. The science has been published in one of the most distinguished medical journals in the world... And the treatment is rapidly progressing through human clinical trials. It could be granted FDA approval in the next 18 months. If that happens, it could generate up to $52.5 billion of revenue for this tiny startup. Now, the company behind this cannabis cure is still private. However, one of America's top venture capitalists has uncovered a loophole... This loophole could allow you to be part of a tiny group of Americans who can get in on a private deal with this company before they go public. This is an extraordinarily rare opportunity. And the window for everyday Americans to get in on this deal is closing rapidly. So if you've ever considered entering the ultra-lucrative arena of cannabis angel investing, this could be your only chance. [Click here to see how a venture capitalist finds and analyzes deals like this... and get a chance to tap into the potential $52.5 billion wave of wealth this discovery could create.]( To your success, Mike Ward Founder, National Institute for Cannabis Investors --------------------------------------------------------------- You are receiving this e-mail at {EMAIL}, as a part of your free subscription to Daily Trade Alliance. Remove your email from this list: [Unsubscribe]( [Manage Your Email Preferences]( To cancel by mail or for any other subscription issues, write us at: Daily Trade Alliance | Attn: Member Services | 1125 N Charles Street | Baltimore, MD 21201 North America: 888.384.8339; International: 443.353.4519; Fax: 410.622.3050 [Contact Customer Service]( Website: [( © 2019 Daily Trade Alliance All Rights Reserved. Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. This Newsletter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of: Daily Trade Alliance. 1125 N Charles Street, Baltimore MD 21201.